Fecal microbiota transplantation has been shown to be an effective treatment for recalcitrant C. difficile infections. The Medicare Part B administrative contractor for Kentucky and Ohio has expressed potential interest in covering the procedure, according to an AAPC report.
A number of commercial payers, such as Aetna and Blue Cross Blue Shield, already cover the procedure for patients with current CDI.
More articles on coding and billing:
MTBC credit line increases to $3M
Foundation for a Healthy Kentucky calls for price transparency
Medicare spending increases with patient age
Recommended Live Webinar on Mar 26, 2026 12:00 PM - 1:00 PM CST